This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Agnieszka Ambrozak: Innovator in Angiogenesis Inhibition
Introduction
Agnieszka Ambrozak is a notable inventor based in Buchs, Switzerland. She has made significant contributions to the field of medical science, particularly in the area of angiogenesis inhibition. Her innovative work has led to the development of novel compounds that have potential therapeutic applications.
Latest Patents
Agnieszka holds 1 patent for her invention titled "Tetrahalogenated compounds useful as inhibitors of angiogenesis." This patent describes methods for inhibiting neoplasms in subjects and outlines the administration of therapeutically effective amounts of tetrahalogenated compounds or their pharmaceutically acceptable salts.
Career Highlights
Throughout her career, Agnieszka has collaborated with various esteemed organizations. Notably, she has worked with the United States of America, as represented by the Secretary of the Department of Health and Human Services, and William D. Figg. Her work has been instrumental in advancing research in her field.
Collaborations
Agnieszka has collaborated with professionals such as Erin Gardner and Michael Gutschow, contributing to the success of her projects and enhancing the impact of her research.
Conclusion
Agnieszka Ambrozak's innovative work in the field of angiogenesis inhibition showcases her dedication to advancing medical science. Her contributions are paving the way for new therapeutic approaches in treating neoplasms.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile